20.80
price down icon1.98%   -0.42
pre-market  시장 영업 전:  20.85   0.05   +0.24%
loading
전일 마감가:
$21.22
열려 있는:
$20.85
하루 거래량:
1.10M
Relative Volume:
0.87
시가총액:
$13.21B
수익:
$2.89B
순이익/손실:
$684.26M
주가수익비율:
19.76
EPS:
1.0524
순현금흐름:
$958.82M
1주 성능:
-6.09%
1개월 성능:
+3.84%
6개월 성능:
-22.47%
1년 성능:
-28.64%
1일 변동 폭
Value
$20.75
$21.02
1주일 범위
Value
$19.89
$22.08
52주 변동 폭
Value
$19.85
$31.88

Genmab Adr Stock (GMAB) Company Profile

Name
명칭
Genmab Adr
Name
전화
-
Name
주소
-
Name
직원
2,635
Name
트위터
@Genmab
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
GMAB's Discussions on Twitter

GMAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GMAB
Genmab Adr
20.80 13.21B 2.89B 684.26M 958.82M 1.0524
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Genmab Adr Stock (GMAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-08 개시 Redburn Atlantic Buy
2024-09-04 재개 Morgan Stanley Equal-Weight
2024-08-20 다운그레이드 JP Morgan Overweight → Neutral
2024-07-15 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2024-02-23 업그레이드 BMO Capital Markets Market Perform → Outperform
2024-01-22 다운그레이드 Citigroup Neutral → Sell
2023-12-06 업그레이드 UBS Neutral → Buy
2023-11-10 업그레이드 Deutsche Bank Hold → Buy
2023-11-08 업그레이드 DNB Markets Sell → Buy
2023-10-18 개시 Exane BNP Paribas Underperform
2023-09-06 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-08-24 개시 BTIG Research Buy
2023-07-14 개시 HSBC Securities Buy
2023-05-31 개시 UBS Neutral
2023-05-12 개시 Morgan Stanley Underweight
2022-12-20 다운그레이드 Citigroup Buy → Neutral
2022-11-14 개시 William Blair Mkt Perform
2022-11-11 다운그레이드 Deutsche Bank Buy → Hold
2022-06-24 개시 BMO Capital Markets Market Perform
2022-05-02 개시 Cowen Market Perform
2022-03-16 업그레이드 UBS Neutral → Buy
2022-01-31 업그레이드 H.C. Wainwright Neutral → Buy
2022-01-03 다운그레이드 Guggenheim Buy → Neutral
2021-12-01 개시 Berenberg Sell
2021-09-16 다운그레이드 Jefferies Buy → Hold
2021-09-07 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-08-24 다운그레이드 H.C. Wainwright Buy → Neutral
2021-04-20 개시 Deutsche Bank Buy
2021-01-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-09-23 다운그레이드 Bryan Garnier Neutral → Sell
2020-09-08 개시 SVB Leerink Mkt Perform
2020-06-25 다운그레이드 Credit Suisse Outperform → Neutral
2020-04-23 개시 Credit Suisse Outperform
2020-02-24 재확인 H.C. Wainwright Buy
2020-01-13 개시 SunTrust Buy
2019-12-12 다운그레이드 Deutsche Bank Buy → Hold
2019-09-13 업그레이드 BofA/Merrill Neutral → Buy
2019-09-12 업그레이드 JP Morgan Neutral → Overweight
2019-08-12 개시 Guggenheim Buy
2019-08-12 개시 Morgan Stanley Overweight
2019-08-12 개시 RBC Capital Mkts Outperform
모두보기

Genmab Adr 주식(GMAB)의 최신 뉴스

pulisher
Jan 17, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN

Jan 17, 2025
pulisher
Jan 14, 2025

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jan 14, 2025
pulisher
Jan 14, 2025

Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance

Jan 14, 2025
pulisher
Jan 03, 2025

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 03, 2025
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 12, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 12, 2024
pulisher
Oct 16, 2024

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024
pulisher
Oct 08, 2024

GMAB or INCY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Oct 08, 2024
pulisher
Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024
pulisher
Sep 24, 2024

Market Resilience: Genmab ADR (GMAB) Finishes Weak at 24.14, Down -5.44 - The Dwinnex

Sep 24, 2024
pulisher
Sep 19, 2024

GANDHIM.APPL Share Price Today Up 13% - Equitymaster

Sep 19, 2024
pulisher
Sep 18, 2024

Glenmark Pharma Share Price Today Down 3% - Equitymaster

Sep 18, 2024
pulisher
Sep 16, 2024

Post-Trade Analysis: Genmab ADR (GMAB) Climbs 1.55, Closing at 26.90 - The Dwinnex

Sep 16, 2024
pulisher
Sep 04, 2024

Market Recap: Genmab ADR (GMAB)’s Negative Momentum, Closing at 27.41 - The Dwinnex

Sep 04, 2024
pulisher
Aug 06, 2024

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy - MSN

Aug 06, 2024
pulisher
Aug 05, 2024

BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls - Yahoo Finance

Aug 05, 2024
pulisher
Aug 02, 2024

Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet - Yahoo Finance

Aug 02, 2024
pulisher
Jul 25, 2024

GMAB vs. CSLLY: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 25, 2024
pulisher
Jul 17, 2024

Wall Street Analysts Believe Genmab (GMAB) Could Rally 52.33%: Here's is How to Trade - Yahoo Finance Australia

Jul 17, 2024
pulisher
Jul 15, 2024

RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com

Jul 15, 2024
pulisher
Jul 09, 2024

GMAB or TECH: Which Is the Better Value Stock Right Now? - Yahoo Finance

Jul 09, 2024
pulisher
Jul 08, 2024

GMAB vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 08, 2024
pulisher
Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024
pulisher
Apr 10, 2024

GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com

Apr 10, 2024
pulisher
Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024
pulisher
Mar 01, 2024

GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com

Mar 01, 2024
pulisher
Jan 17, 2024

New Strong Buy Stocks for January 17th - Yahoo Finance

Jan 17, 2024
pulisher
Dec 12, 2023

GMAB: 3 Biotech Stocks to Boost Portfolios - StockNews.com

Dec 12, 2023
pulisher
Nov 10, 2023

GMAB: 3 Biotech Stocks to Watch in November - StockNews.com

Nov 10, 2023
pulisher
Sep 05, 2023

Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch

Sep 05, 2023
pulisher
May 19, 2023

GMAB: 2 Explosive Biotech Stocks to Own - StockNews.com

May 19, 2023
pulisher
Feb 27, 2023

Stocks Generating Improved Relative Strength: Genmab ADR - Investor's Business Daily

Feb 27, 2023
pulisher
Feb 23, 2023

Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily

Feb 23, 2023
pulisher
Feb 10, 2023

Moderna Stock Getting Closer To Key Technical Benchmark - Inkl

Feb 10, 2023
pulisher
Feb 06, 2023

Stock Upgrades: Legend Biotech ADR Shows Rising Relative Strength - Investor's Business Daily

Feb 06, 2023
pulisher
Jan 23, 2023

GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada

Jan 23, 2023
pulisher
Jan 18, 2023

Ascendis Pharma ADR Scores Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily

Jan 18, 2023
pulisher
Dec 12, 2022

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Dec 12, 2022
pulisher
Nov 29, 2022

Horizon Therapeutics Is A Stock With Rising Relative Strength - Investor's Business Daily

Nov 29, 2022
pulisher
Nov 24, 2022

Genmab's chief development officer sells shares in US - MedWatch

Nov 24, 2022
pulisher
Aug 31, 2022

Stocks To Watch: Genmab Sees Relative Strength Rating Jump To 82 - Investor's Business Daily

Aug 31, 2022
pulisher
Aug 09, 2022

Zealand Pharma to delist in US - MedWatch

Aug 09, 2022
pulisher
May 10, 2022

Should You Buy Genmab (GMAB) Ahead of Earnings? - Yahoo Finance

May 10, 2022
pulisher
Mar 29, 2021

Inside Genmab's blockbuster IPO - IR Magazine

Mar 29, 2021
pulisher
Feb 24, 2021

Pipeline of Proprietary Antibodies - flow – Deutsche Bank

Feb 24, 2021
pulisher
Jan 13, 2021

Emergent BioSolutions Sees Its Composite Rating Rise To 97 - Investor's Business Daily

Jan 13, 2021
pulisher
Jan 05, 2021

Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drug - Yahoo Finance

Jan 05, 2021
pulisher
Jun 16, 2020

The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga

Jun 16, 2020
pulisher
Aug 19, 2019

Genmab's offering and listing in the USA - Bech-Bruun

Aug 19, 2019
pulisher
Aug 08, 2019

Genmab AS (GMAB) Stock Price, Trades & News - GuruFocus.com

Aug 08, 2019

Genmab Adr (GMAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
자본화:     |  볼륨(24시간):